These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 33519200)

  • 21. Human cell receptors: potential drug targets to combat COVID-19.
    Raghav PK; Kalyanaraman K; Kumar D
    Amino Acids; 2021 Jun; 53(6):813-842. PubMed ID: 33950300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19.
    Bhavaniramya S; Ramar V; Vishnupriya S; Palaniappan R; Sibiya A; Vaseeharan B
    Curr Mol Pharmacol; 2022; 15(2):393-417. PubMed ID: 34382513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints.
    Rai M; Bonde S; Yadav A; Plekhanova Y; Reshetilov A; Gupta I; Golińska P; Pandit R; Ingle AP
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1299-1308. PubMed ID: 33164589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves.
    Rahman A; Roy KJ; Deb GK; Ha T; Rahman S; Aktar MK; Ali MI; Kafi MA; Choi JW
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
    Khade SM; Yabaji SM; Srivastava J
    Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.
    Zhang Y; Almazi JG; Ong HX; Johansen MD; Ledger S; Traini D; Hansbro PM; Kelleher AD; Ahlenstiel CL
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primed for global coronavirus pandemic: Emerging research and clinical outcome.
    Ahamad S; Branch S; Harrelson S; Hussain MK; Saquib M; Khan S
    Eur J Med Chem; 2021 Jan; 209():112862. PubMed ID: 33070079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines.
    Awadasseid A; Wu Y; Tanaka Y; Zhang W
    Biomed Pharmacother; 2021 May; 137():111330. PubMed ID: 33550043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2.
    Kamat S; Kumari M; Jayabaskaran C
    J Control Release; 2021 Oct; 338():813-836. PubMed ID: 34478750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How can nanotechnology help to combat COVID-19? Opportunities and urgent need.
    Campos EVR; Pereira AES; de Oliveira JL; Carvalho LB; Guilger-Casagrande M; de Lima R; Fraceto LF
    J Nanobiotechnology; 2020 Sep; 18(1):125. PubMed ID: 32891146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view.
    Chatterjee S; Mishra S; Chowdhury KD; Ghosh CK; Saha KD
    Life Sci; 2021 Aug; 278():119580. PubMed ID: 33991549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoprotection from SARS-COV-2: would nanotechnology help in Personal Protection Equipment (PPE) to control the transmission of COVID-19?
    Phuna ZX; Panda BP; Hawala Shivashekaregowda NK; Madhavan P
    Int J Environ Health Res; 2023 Jul; 33(7):670-699. PubMed ID: 35253535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.
    Vlachakis D; Papakonstantinou E; Mitsis T; Pierouli K; Diakou I; Chrousos G; Bacopoulou F
    Food Chem Toxicol; 2020 Dec; 146():111805. PubMed ID: 33038452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.